Lastly, our third growth initiative is to expand into other addressable markets. This month, Varian went live across the Tennessee Oncology network with an implementation of Noona patient-reported outcomes and symptoms management platform. We also continue to look at inorganic opportunities to leverage Varian's core strengths to reach more patients and drive long-term growth. Overall, we're pleased with the progress we made in the second quarter. We remain dedicated to providing customers with a full spectrum of intelligent advanced tools to help improve patient outcomes and achieve our long-term growth strategy.